Epidemiology of Hypertrophic Cardiomyopathy in the United States From 2016 to 2023
In this administrative claims-based study, the prevalence of HCM from 2016 to 2023 was 1/327 individuals, which translates to an estimated 832,956 HCM cases in the United States.
Authors
- Ralph J. Riello (ORCID: https://orcid.org/0000-0003-1884-6269)
- Ahmad Munir Masri
- Sanatan Shreay
- Nihar R. Desai (ORCID: https://orcid.org/0000-0003-2384-2545)
- P. Gebrehiwet (ORCID: https://orcid.org/0000-0002-7692-2189)
- Kian Farajkhah
- Michael Butzner
- Theodore Abraham
- Anjali T. Owens
- Andrew K. ElHabr
- Turgay Ayer
Institutions
- Georgia Institute of Technology (US)
- Oregon Health & Science University (US)
- University of California, San Francisco (US)
- Hospital of the University of Pennsylvania (US)
- Yale University (US)
- Massachusetts General Hospital (US)
- Cytokinetics (United States) (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1016/j.jacadv.2025.102552
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00